Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Multiple Myeloma 4Parkinson Disease 4, Autosomal Dominant Lewy Body 3Carcinoma, Non-Small-Cell Lung 2Ulcer 1Stomatitis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Philadelphia Chromosome 1Ovarian Neoplasms 1Neurofibromatosis 1 1Neoplasms 1Neoplasm Metastasis 1Melanoma 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1Head and Neck Neoplasms 1Glioblastoma 1Fallopian Tube Neoplasms 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Squamous Cell 1Burkitt Lymphoma 1Adenocarcinoma 1

Interventions

Low-Level Light Therapy 2Xylitol 1Mouthwashes 1Methylprednisolone 1Betaine 1Analgesia 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Ulcer × Acetaminophen × Clear all
NCT03972527 2024-08-21

Photobiomodulation to Demonstrate Safety and Reduce the Incidence of Oral Mucositis in Adult Head & Neck Cancer Patients

MuReva Phototherapy Inc.

Phase NA Completed
85 enrolled
Head & Neck

Head and Neck Neoplasms, Stomatitis, Ulcer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡